瘤微环境中的单细胞菌模式调节细胞间通信,影响肝细胞癌的进展和预后
Zhengyan Li1, Wei Chen1, Shu Yao1
1Department of Hepatobiliary Surgery, Daping Hospital, Army Medical University, Chongqing, China.
Frontiers in immunology
|January 21, 2025
概括
肝细胞癌 (HCC) 中的线粒会影响细胞通信和患者的存活率,但不会影响免疫治疗的有效性. 准线粒可能会改善HCC患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肝细胞癌 (HCC) 是一种常见的消化系统恶性瘤,具有显著的死亡率.
- 目前的治疗方法,包括免疫疗法,面临着局限性,导致患者的治疗结果低于最佳.
研究的目的:
- 为了研究 mitoophagy 在肝细胞癌瘤微环境 (TME) 中的作用.
- 探索线粒对细胞间通信,瘤进展和HCC患者预后的影响.
主要方法:
- 从HCC患者 (25,189个细胞) 的两个单细胞RNA测序 (scRNA-seq) 数据集的分析.
- 在癌症相关纤维细胞 (CAF),T细胞,B细胞和瘤相关巨细胞 (TAMs) 中利用非负矩阵因子化 (NMF) 进行线粒细胞衰变模式识别.
- 使用CellChat进行细胞间通信分析,使用Monocle进行伪时间轨迹分析,使用SCENIC进行基因调控网络调查.
主要成果:
- 在HCC样本中确定了22个和7种主要细胞类型,揭示了复杂的细胞间通信.
- 在CAFs,TAMs,CD8+ T细胞和B细胞中发现了与mitophagy相关的亚型,这些亚型表现出不同的生物状态和代谢途径.
- 在瘤样本中观察到较高的线粒细胞衰竭水平,线粒细胞衰竭基因的改变与总生存率相关,但与免疫疗法的疗效无关.
结论:
- 在HCC TME内的线粒显著调节细胞间通信,影响瘤进展和患者预后.
- 向线粒菌是一种潜在的治疗策略,可以改善HCC患者的长期治疗结果.
更多相关视频
11:59Author Spotlight: Detection of Mitophagy in Caenorhabditis elegans and Mammalian Cells Using Organelle-Specific Dyes
Published on: May 19, 2023
2.1K
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
6.2K
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
